# Post-thrombectomy Intra-arterial Tenecteplase for Acute manaGement of Non-retrievable Thrombus and No-reflow in Emergent Stroke

Study · id `cardio:ct-nct05892510` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05892510](<https://clinicaltrials.gov/study/NCT05892510>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT05892510

Browse, organ or system: Brain  
Browse, condition area: Stroke  

## In plain language

A phase 2/3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 462 participants.

## Technical summary

Registry record NCT05892510. Randomized; quadruple masking; primary purpose treatment. Start 2024-06-01 (actual); primary completion 2027-08-30 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase: Phase 2/3
- Enrolled: 462 participants (planned count; ClinicalTrials.gov record NCT05892510, source copy `cardio:ctgov-nct05892510-2026-05-18`, retrieved 2026-10-26)
- Started: 2024-06-01 (actual) (ClinicalTrials.gov record NCT05892510, source copy `cardio:ctgov-nct05892510-2026-05-18`, retrieved 2026-10-26)
- Primary completion: 2027-08-30 (anticipated) (ClinicalTrials.gov record NCT05892510, source copy `cardio:ctgov-nct05892510-2026-05-18`, retrieved 2026-10-26)
- Completion: 2027-11-30 (anticipated) (ClinicalTrials.gov record NCT05892510, source copy `cardio:ctgov-nct05892510-2026-05-18`, retrieved 2026-10-26)
- Countries: Australia; New Zealand (ClinicalTrials.gov record NCT05892510, source copy `cardio:ctgov-nct05892510-2026-05-18`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05892510-2026-05-18`, retrieved 2026-10-26)

## The registry's words

- Brief title: Post-thrombectomy Intra-arterial Tenecteplase for Acute manaGement of Non-retrievable Thrombus and No-reflow in Emergent Stroke
- Condition: Ischemic Stroke, Acute
- Condition: Cerebrovascular Disorders
- Condition: Brain Disorder
- Condition: Central Nervous System Diseases
- Intervention (Drug): Intra-arterial tenecteplase injection at the completion of thrombectomy
- Intervention (Drug): Placebo
- Lead sponsor: University of Melbourne
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Ischemic stroke (`cardio:ischemic-stroke`)
- Registry condition terms include this condition: Stroke (`core:stroke`)
- Registry lists this organization as the lead sponsor: University of Melbourne (`cardio:org-university-of-melbourne`)

## Provenance

Content hash: 5df5f2b1b53032cd544395e8dfd464313316a4b62fc4c582f5aefdc478494022
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
